Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
97.24
+2.03 (2.13%)
At close: Sep 30, 2026, 4:00 PM EDT
96.11
-1.13 (-1.16%)
After-hours: Sep 30, 2026, 4:22 PM EDT
Hinge Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Hinge Health stock has a consensus rating of "Buy" and an average price target of $108.19. The average 1-year stock price forecast is 11.26% higher than the current stock price, while the lowest is $90 (-7.45%) and the highest is $140 (+43.97%).
Price Target: $108.19 (+11.26%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hinge Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Initiates $110 | Buy | Initiates | $110 | +13.12% | Sep 29, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 28, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $85 → $90 | Hold | Maintains | $85 → $90 | -7.45% | Sep 22, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $96 → $115 | Buy | Maintains | $96 → $115 | +18.26% | Sep 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $117 | Buy | Maintains | $117 | +20.32% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
860.38M
from 587.86M
Increased by 46.36%
Revenue Next Year
1.09B
from 860.38M
Increased by 26.35%
EPS This Year
2.40
from 2.62
Decreased by -8.43%
EPS Next Year
3.06
from 2.40
Increased by 27.44%
EPS and Forward PE are based on non-GAAP adjusted numbers.